TANG CAPITAL MANAGEMENT LLC Q4 2020 Filing
Filed February 16, 2021
Portfolio Value
$655.0B
Holdings
11
Report Date
Q4 2020
Filing Type
13F-HR
All Holdings (11 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —ODONATE THERAPEUTICS INC | 15,514,566 | $297.9B | 45.48% | |
| 2 | RCKTROCKET PHARMACEUTICALS INC | 2,965,485 | $162.6B | 24.83% | |
| 3 | APVOAPTEVO THERAPEUTICS INC | 1,760,000 | $64.5B | 9.85% | |
| 4 | ANABANAPTYSBIO INC | 2,628,678 | $56.5B | 8.63% | |
| 5 | —LA JOLLA PHARMACEUTICAL CO | 9,405,490 | $36.5B | 5.57% | |
| 6 | CHRSCOHERUS BIOSCIENCES INC | 650,000 | $11.3B | 1.72% | |
| 7 | —VINCERA PHARMA INC | 500,000 | $9.6B | 1.47% | |
| 8 | RLMDRELMADA THERAPEUTICS INC | 200,000 | $6.4B | 0.98% | |
| 9 | —BCTG ACQUISITION CORP | 468,750 | $5.4B | 0.82% | |
| 10 | EQEQUILLIUM INC | 600,000 | $3.2B | 0.49% | |
| 11 | —VINCERA PHARMA INC | 330,205 | $1.1B | 0.17% |